Duchenne cardiomyopathy: targeting ROS and NOX4 as a promising therapeutic strategy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Duchenne cardiomyopathy: targeting ROS and NOX4 as a promising therapeutic strategy

Published:2023-02-01 Issue:2 Volume:27 Page:91-95
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Sampaolesi Maurilio¹²,Janssens Stefan³,Duelen Robin¹³

Affiliation:

1. Translational Cardiomyology, Stem Cell and Developmental Biology, Department of Development and Regeneration, KU Leuven, Leuven, Belgium

2. Histology and Medical Embryology, Department of Anatomy, Histology, Forensic Medicine and Orthopedics, Sapienza University of Rome, Rome, Italy

3. Cardiology, Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium

Funder

Research Foundation Flanders (FWO

Small Research Infrastructure KU Leuven – BioAssemblyBot 400

Interreg – Euregio Meuse-Rhine

Italian Ministry of Health – Ricerca Finalizzata

RD was supported by KU Leuven Rondoufonds voor Duchenne Onderzoek

KU Leuven Postdoctoral Mandate Type 1

MS is a recipient of the Hercules Foundation grant

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2023.2187287

Reference20 articles.

1. Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis

2. Cardiac Pathophysiology and the Future of Cardiac Therapies in Duchenne Muscular Dystrophy

3. Cardiovascular Disease in Duchenne Muscular Dystrophy

4. Alternative Splicing of NOX4 in the Failing Human Heart

5. NADPH Oxidases (NOX): An Overview from Discovery, Molecular Mechanisms to Physiology and Pathology

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases;Signal Transduction and Targeted Therapy;2024-03-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3